Back to Trades
Hite Christopher
EVP & ChairmanPartneringCIK 0001814238
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 3
- Active
- 2025–2026
Hite Christopher, EVP & Chairman, Partnering, has filed 5 reports across 3 companies, totaling $8.8M in disclosed volume. Sales ($8.2M) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jun 25 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Chairman, Partnering | Sell | $8.2M |
| Apr 20 | KLRA Kailera Therapeutics, Inc. | Hite Christopher | Insider | Other | $0 |
| Apr 16 | KLRA Kailera Therapeutics, Inc. | Hite Christopher | Insider | Other | $0 |
| Mar 9 | VERA Vera Therapeutics, Inc. | Hite Christopher | Insider | Other | $0 |
| Aug 8 | RPRX Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Grant | $0 |
5 filings